Literature DB >> 22348186

Bacillus cereus catheter related bloodstream infection in a patient with acute lymphoblastic leukemia.

N Gurler1, L Oksuz, M Muftuoglu, Fd Sargin, Sk Besisik.   

Abstract

Bacillus cereus infection is rarely associated with actual infection and for this reason single positive blood culture is usually regarded as contamination . However it may cause a number of infections, such catheter-related bloodstream infections. Significant catheter-related bloodstream infections (CRBSI) caused by Bacillus spp. are mainly due to B. cereus and have been predominantly reported in immunocompromised hosts. Catheter removal is generally advised for management of infection. In this report, catheter-related bacteremia caused by B. cereus in a patient with acute lymphoblast c leukemia (ALL) in Istanbul Medical Faculty was presented.

Entities:  

Year:  2012        PMID: 22348186      PMCID: PMC3279319          DOI: 10.4084/MJHID.2012.004

Source DB:  PubMed          Journal:  Mediterr J Hematol Infect Dis        ISSN: 2035-3006            Impact factor:   2.576


Case

A 44-year old man presented with fatigue, weight loss, epistaxis and high fever. Physical examination was insignificant except for pallorness, Complete blood count revealed total white blood cells at 130,000/mm3 hemoglobin at 7.6 g/dl, platelet 30,000/mm3. He was diagnosed with Pre-B acute lymphoblastic leukemia following bone marrow aspiration, biyopsy and flow cytometric analysis. Cytogenetic analysis showed a karyotype of 45, XY del 9 del 16. The patient achieved complete hematological remission accompanied by disappearance of cytogenetic abnormalities following induction chemotherapy with BFM ALL protocol. The patient was considered to be a candidate for stem cell transplantion because of initial patient characteristics indicating high risk for ALL relapse (Age, complex clonal cytogenetic abnormalities, high total leukocyte count). An HLA-identical unrelated donor, living abroad, was identified. A double-lumen Hickman–catheter (Bard 12.0 Fr, Round Dual Lumen) was inserted by surgical cut-down to access the right subclavian vein which would be necessary for allogeneic stem cell transplantation. Two cycles of consolidation chemotherapy were administered before proceeding to stem cell transplantation. Three weeks later central nervous system (CNS) relapse of ALL occurred, which is treated with four cycles of intrathecal chemoterapy, comprising of methotrexate, cytosine arabinoside and dexamethasone. At the same time a cycle of cytosine arabinoside and cyclophosphamide-based chemotherapy was administered. Stem cell transplantation was planned to be carried out in a month. Three weeks later the patient presented with high fever and headache. Blood cultures were obtained from the catheter and from a peripheral vein and evaluated on the BACTEC 9120 system (Becton Dickinson, USA). Bacillus spp. was isolated from the cathether while blood culture obtained from the peripheral vein remained negative. It was regarded as contaminant so that complete identification of Bacillus species was not carried out. Lumbar puncture was performed and CNS involvement was documented. Lymphoblastic cells were seen on peripheral blood smear which is considered compatible with hematological relapse. Intrathecal chemotherapy, and methotrexate and high-dose cytosine arabinoside-based systemic reinduction chemotherapy were started. One week after chemotherapy he developed chills and high fever as absolute neutrophil count was 100/mm3. The physical examination was noncontributary and blood cultures were collected from the catheter and a peripheral vein. Two blood culture bottles (one from the catheter and one from the peripheral) were positive gram-positive bacilli after three days of incubation at 35°C. The organism produced large, greenish colonies. The bacterium was identified as B.cereus on the basis of Gram staining, colony morphology, motility, lecitinase activity. The bacterial identification was confirmed as B.cereus using VITEK identification system (bioMeriéux, France). The strain was sensitive to imipenem, vancomycin, gentamicin and ciprofloxacin, whereas resistant to penicillin, cephalosporins and co-trimoxazole. He was started on piperacillin-tazobactam at a dose of 4 g/500 mg every 6 h emprically before blood culture result was available. Vancomycin was added to the treatment regimen due to incomplete clinical and laboratory response. Hickmann catheter, which was inserted about ten months ago, was accepted as the focus of infection and, prolonged maintenance of the catheter was thought to be no more possible. High fever subsided completely upon removal. Hematological remission was achieved and allogeneic stem cell transplantation was scheduled to be performed one week later.

Conclusion

Bacillus species are known to be responsible for several systemic infections, especially in immunocompromised patients. The most commonly reported systemic infection is bacteremia.2,3 Bacillus bacteremia can be serious and even fatal, in immunocompromised patients, such as neutropenia. The most common feature in true Bacillus bacteremia is the presence of an intravascular catheter. B. cereus produce biofilms, which can play a major role in attachment to catheters.10 Bacillus species are associated with CRBSIs and they have been well documented, especially among patients with hematological malignancies.10,22 Some of the reported cases in the literature were shown in the table 1. The table shows that the majority of the patients have abdominal symptoms, but our patients not.
Table 1

Reported cases of immunsupressed patients with Bacillus cereus bacteremia.

ReferenceYearAgeDiagnosisIntravenous catheterAbdominal symptomsOutcome
11198867Acute lymphoblastic leukemiaPresentDeath
12199343Acute myelogenous leukemiaYesPresentDeath
12199315Acute myeloid leukemiaYesPresentDeath
13199720Acute lymphoblastic leukemia(relapse)PresentDeath
14199764Acute myeloid leukemiaYesPresentDeath
13199810Acute lymphoblastic leukemia(relapse)PresentRecovery
15199913Acute lymphoblastic leukemiaYesPresentSurvived
15199915Acute lymphoblastic leukemia(relapse)YesPresentDeath
16199930Acute myeloid leukemiaYesPresentDeath
16199943Acute myeloid leukemiaYesPresentDeath
16199914Acute lymphoblastic leukemiaYesNoneSurvived
17200237Acute myeloid leukemiaPresentRecovery
320035HemophiliaYesNoneRecovery
18200534Acute lymphoblastic leukemiaYesPresentDeath
19200633Biphenotypic acute leukemiaYesPresentDeath
20200623Acute myeloid leukemiaYesPresentDeath
20200634Acute lymphoblastic leukemiaYesNoneRecovery
20200671Acute myeloid leukemiaYesNoneRecovery
21200864Acute myeloid leukemiaPresentDeath
Present case201044Acute lymphoblastic leukemiaYesNoneRecovery
The isolation of Bacillus species raises the possibility of contamination on the basis of Bacillus spp. being common contaminants of blood cultures.8 The ability of Bacillus spp to form a biofilm matrix and the adherence properties account for their relation with central venous catheter (CVC) infections.4 Catheter-related Bacillus spp infections are difficult to eradicate because of slime formation and biofilm production on the catheter surface. Most published data are based on small case series and data regarding the management of Bacillus spp. infections are still lacking. Recently conducted study, which is currently the largest series reported, has concluded that retention of the catheter beyond 72 hours after the onset of bacteremia was related to a higher incidence of recurrent Bacillus bacteremia.2 The drug of choice for Bacillus infections is vancomycin.5 Despite the proper agent and appropriate length of treatment the clinical outcome remains unsatisfactory. This is largely due to inactivity of vancomycin against the organisms dwelling in biofilm layer and slime production, making the organism highly adherent to the catheters. Based on preliminary data and available “Infectious Diseases Society of America (IDSA)” guideline early catheter removal should be the cornerstone of Bacillus bacteremia management.2,6,7 In compatible with this report, our patient developed intermittent fever spikes under the appropriate antimicrobial therapy even though neutropenia resolved with G-CSF support. The Hickmann catheter was removed on the 10th day of vancomycin therapy. Septicemia-related thrombocytopenia unresponsive to aggressive thrombocyte transfusion hindered early removal of the catheter. Catheter tip culture remained negative, which is attributed to ongoing antibiotherapy consisting of piperacillin-tazobactam and vancomycin. According to the IDSA guidelines published in 2009,6 Bacillus CRBSIs should be considered after blood contamination is ruled out on the basis of multiple positive culture results, with at least one blood culture sample obtained from a peripheral vein. It is also suggested that the catheters should be removed if the diagnosis is certain, except for in patients having uncomplicated CRBSI involving long-term catheters because of limited access sites and requiring long-term vascular access for survival. Bacillus cereus is a growing concern as a cause of life-threatening infections in patients with hematologic malignancies.9 B.cereus should be suspected in immunosuppressed patients with intravascular catheter. B.cereus septicemia may be fatal in immunocompromised hosts despite broad-spectrum appropriate treatment. Catheter removal is essential for prevention of recurrent bacteremia. Long-term catheter salvage should be reserved for appropriate patient group.
  21 in total

1.  Long-term central venous catheter salvage in patients with Bacillus bacteremia.

Authors:  Hyun Gu Park; Sang-Ho Choi
Journal:  Medicine (Baltimore)       Date:  2010-09       Impact factor: 1.889

Review 2.  Catheter-related bloodstream infections: catheter management according to pathogen.

Authors:  Leonidia Leonidou; Charalambos A Gogos
Journal:  Int J Antimicrob Agents       Date:  2010-12-03       Impact factor: 5.283

3.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

4.  Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes.

Authors:  V Ozkocaman; T Ozcelik; R Ali; F Ozkalemkas; A Ozkan; C Ozakin; H Akalin; A Ursavas; F Coskun; B Ener; A Tunali
Journal:  J Hosp Infect       Date:  2006-08-07       Impact factor: 3.926

5.  Fulminant sepsis caused by Bacillus cereus in patients with hematologic malignancies: analysis of its prognosis and risk factors.

Authors:  Daichi Inoue; Yuya Nagai; Minako Mori; Seiji Nagano; Yoko Takiuchi; Hiroshi Arima; Takaharu Kimura; Sonoko Shimoji; Katsuhiro Togami; Sumie Tabata; Soshi Yanagita; Akiko Matsushita; Kenichi Nagai; Yukihiro Imai; Hiroshi Takegawa; Takayuki Takahashi
Journal:  Leuk Lymphoma       Date:  2010-05

Review 6.  Bacillus cereus, a volatile human pathogen.

Authors:  Edward J Bottone
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Necrotizing gastritis due to Bacillus cereus in an immunocompromised patient.

Authors:  J Le Scanff; I Mohammedi; A Thiebaut; O Martin; L Argaud; D Robert
Journal:  Infection       Date:  2006-04       Impact factor: 3.553

8.  Fulminant septicaemic syndrome of Bacillus cereus: three case reports.

Authors:  M O Musa; M Al Douri; S Khan; T Shafi; A Al Humaidh; A M Al Rasheed
Journal:  J Infect       Date:  1999-09       Impact factor: 6.072

Review 9.  [Bacillus cereus sepsis and subarachnoid hemorrhage following consolidation chemotherapy for acute myelogenous leukemia].

Authors:  Eri Kawatani; Yuki Kishikawa; Chikahiro Sankoda; Nobuo Kuwahara; Daisuke Mori; Kouichi Osoegawa; Eijo Matsuishi; Hisashi Gondo
Journal:  Rinsho Ketsueki       Date:  2009-04

10.  Management of Bacillus bacteremia: the need for catheter removal.

Authors:  Rawan Kassar; Ray Hachem; Ying Jiang; Anne-Marie Chaftari; Issam Raad
Journal:  Medicine (Baltimore)       Date:  2009-09       Impact factor: 1.889

View more
  9 in total

1.  A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancer.

Authors:  David S Shulman; Preeti Mehrotra; Traci M Blonquist; Andrew Capraro; Leslie E Lehmann; Lewis B Silverman; Neeraj K Surana; Andrew E Place
Journal:  Pediatr Blood Cancer       Date:  2018-12-11       Impact factor: 3.167

2.  Erratum to: Seasonal trend and clinical presentation of Bacillus cereus bloodstream infection: association with summer and indwelling catheter.

Authors:  K Kato; Y Matsumura; M Yamamoto; M Nagao; Y Ito; S Takakura; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05       Impact factor: 3.267

3.  Seasonal trend and clinical presentation of Bacillus cereus bloodstream infection: association with summer and indwelling catheter.

Authors:  K Kato; Y Matsumura; M Yamamoto; M Nagao; Y Ito; S Takakura; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-03       Impact factor: 3.267

4.  Cutaneous infection due to Bacillus cereus: a case report.

Authors:  Mohammad Esmkhani; Saeed Shams
Journal:  BMC Infect Dis       Date:  2022-04-21       Impact factor: 3.667

5.  Identification of pBC218/pBC210 Genes of Bacillus cereus G9241 in Five Florida Soils Using qPCR.

Authors:  Vicki Ann Luna; Kimmy Nguyen; Damian H Gilling
Journal:  Int Sch Res Notices       Date:  2014-07-03

6.  ppGpp signaling plays a critical role in virulence of Acinetobacter baumannii.

Authors:  Kyeongmin Kim; Maidul Islam; Hye-Won Jung; Daejin Lim; Kwangsoo Kim; Sung-Gwon Lee; Chungoo Park; Je Chul Lee; Minsang Shin
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 7.  Bacillus cereus sensu lato biofilm formation and its ecological importance.

Authors:  Yicen Lin; Romain Briandet; Ákos T Kovács
Journal:  Biofilm       Date:  2022-02-15

8.  Successful Treatment of Bacillus cereus Bacteremia in a Patient with Propionic Acidemia.

Authors:  Fatma Deniz Aygun; Fatih Aygun; Halit Cam
Journal:  Case Rep Pediatr       Date:  2016-04-19

9.  Biofilm formation displays intrinsic offensive and defensive features of Bacillus cereus.

Authors:  Joaquín Caro-Astorga; Elrike Frenzel; James R Perkins; Ana Álvarez-Mena; Antonio de Vicente; Juan A G Ranea; Oscar P Kuipers; Diego Romero
Journal:  NPJ Biofilms Microbiomes       Date:  2020-01-15       Impact factor: 7.290

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.